IT1204826B - Composizioni farmaceutiche per inalazione - Google Patents

Composizioni farmaceutiche per inalazione

Info

Publication number
IT1204826B
IT1204826B IT19625/86A IT1962586A IT1204826B IT 1204826 B IT1204826 B IT 1204826B IT 19625/86 A IT19625/86 A IT 19625/86A IT 1962586 A IT1962586 A IT 1962586A IT 1204826 B IT1204826 B IT 1204826B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
inhalation pharmaceutical
inhalation
microgranules
conglomerate
Prior art date
Application number
IT19625/86A
Other languages
English (en)
Other versions
IT8619625A0 (it
Inventor
Paolo Chiesi
Luciana Pavesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IT8619625A0 publication Critical patent/IT8619625A0/it
Priority to IT19625/86A priority Critical patent/IT1204826B/it
Priority to EP87901468A priority patent/EP0258356B1/en
Priority to DE198787901468T priority patent/DE258356T1/de
Priority to JP62501911A priority patent/JPS63502895A/ja
Priority to AT87901468T priority patent/ATE94755T1/de
Priority to AU71645/87A priority patent/AU597964B2/en
Priority to DE87901468T priority patent/DE3787502T2/de
Priority to HU871760A priority patent/HU202748B/hu
Priority to KR1019870701005A priority patent/KR940000099B1/ko
Priority to ES198787102816T priority patent/ES2031839T3/es
Priority to EP87102816A priority patent/EP0239798B1/en
Priority to PCT/EP1987/000118 priority patent/WO1987005213A1/en
Priority to ZA871523A priority patent/ZA871523B/xx
Priority to CA000531054A priority patent/CA1297012C/en
Priority to NZ219484A priority patent/NZ219484A/xx
Priority to MYPI87002294A priority patent/MY102928A/en
Priority to FI874710A priority patent/FI90015C/fi
Priority to NO874590A priority patent/NO874590L/no
Priority to GR88300017T priority patent/GR880300017T1/el
Application granted granted Critical
Publication of IT1204826B publication Critical patent/IT1204826B/it
Priority to GR90400695T priority patent/GR3000879T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT19625/86A 1986-03-04 1986-03-04 Composizioni farmaceutiche per inalazione IT1204826B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT19625/86A IT1204826B (it) 1986-03-04 1986-03-04 Composizioni farmaceutiche per inalazione
EP87102816A EP0239798B1 (en) 1986-03-04 1987-02-27 New pharmaceutical compositions for inhalation
DE198787901468T DE258356T1 (de) 1986-03-04 1987-02-27 Pharmazeutische zusammensetzungen zum einatmen.
JP62501911A JPS63502895A (ja) 1986-03-04 1987-02-27 新規な吸入用製薬組成物
AT87901468T ATE94755T1 (de) 1986-03-04 1987-02-27 Pharmazeutische zusammensetzungen zum einatmen.
AU71645/87A AU597964B2 (en) 1986-03-04 1987-02-27 New pharmaceutical compositions for inhalation
DE87901468T DE3787502T2 (de) 1986-03-04 1987-02-27 Pharmazeutische zusammensetzungen zum einatmen.
HU871760A HU202748B (en) 1986-03-04 1987-02-27 Process for producing filling material usable in inhalation pharmaceutical compositions
KR1019870701005A KR940000099B1 (ko) 1986-03-04 1987-02-27 신규 흡입용 제약 조성물
ES198787102816T ES2031839T3 (es) 1986-03-04 1987-02-27 Nuevas composiciones farmaceuticas para inhalacion.
EP87901468A EP0258356B1 (en) 1986-03-04 1987-02-27 New pharmaceutical compositions for inhalation
PCT/EP1987/000118 WO1987005213A1 (en) 1986-03-04 1987-02-27 New pharmaceutical compositions for inhalation
ZA871523A ZA871523B (en) 1986-03-04 1987-03-03 Pharmaceutical compositions for inhalation
CA000531054A CA1297012C (en) 1986-03-04 1987-03-03 Pharmaceutical compositions for inhalation
NZ219484A NZ219484A (en) 1986-03-04 1987-03-03 Microgranular excipient for inhalation
MYPI87002294A MY102928A (en) 1986-03-04 1987-09-29 New pharmaceutical compositions for inhalation
FI874710A FI90015C (fi) 1986-03-04 1987-10-26 Fyllnadsaemne och dess anvaendning i farmaceutiska sammansaettningar foer inhalation
NO874590A NO874590L (no) 1986-03-04 1987-11-03 BŸrer fra farmaceutiske blandinger.
GR88300017T GR880300017T1 (en) 1986-03-04 1988-05-20 New pharmaceutical compositions for inhalation
GR90400695T GR3000879T3 (en) 1986-03-04 1990-09-27 New pharmaceutical compositions for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19625/86A IT1204826B (it) 1986-03-04 1986-03-04 Composizioni farmaceutiche per inalazione

Publications (2)

Publication Number Publication Date
IT8619625A0 IT8619625A0 (it) 1986-03-04
IT1204826B true IT1204826B (it) 1989-03-10

Family

ID=11159814

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19625/86A IT1204826B (it) 1986-03-04 1986-03-04 Composizioni farmaceutiche per inalazione

Country Status (17)

Country Link
EP (2) EP0258356B1 (it)
JP (1) JPS63502895A (it)
KR (1) KR940000099B1 (it)
AT (1) ATE94755T1 (it)
AU (1) AU597964B2 (it)
CA (1) CA1297012C (it)
DE (2) DE258356T1 (it)
ES (1) ES2031839T3 (it)
FI (1) FI90015C (it)
GR (2) GR880300017T1 (it)
HU (1) HU202748B (it)
IT (1) IT1204826B (it)
MY (1) MY102928A (it)
NO (1) NO874590L (it)
NZ (1) NZ219484A (it)
WO (1) WO1987005213A1 (it)
ZA (1) ZA871523B (it)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
JPH0558911A (ja) * 1991-08-27 1993-03-09 N D Shinyaku Kaihatsu Kenkyusho:Kk 鎮咳去痰剤
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EP0806940B1 (en) 1994-12-22 2003-04-09 AstraZeneca AB Aerosol drug formulations
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6599883B1 (en) * 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
AU756852B2 (en) * 1998-11-13 2003-01-23 Jagotec Ag Dry powder for inhalation
ES2286881T3 (es) 1999-03-05 2007-12-01 Chiesi Farmaceutici S.P.A. Composiciones farmaceuticas en polvo mejoradas para inhalacion.
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
PT1296651E (pt) * 2000-06-27 2008-02-12 Vectura Ltd Método para fazer partículas para serem usadas numa composição farmacêutica
EP2283818B1 (en) * 2000-11-30 2017-08-02 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP2168571B1 (en) 2000-11-30 2018-08-22 Vectura Limited Particles for use in a Pharmaceutical Composition
NZ526059A (en) † 2000-11-30 2005-05-27 Vectura Ltd Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
WO2003024396A2 (en) 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
JP2005508220A (ja) * 2001-10-24 2005-03-31 パーリ・ゲーエムベーハー 薬用組成物調製用具
EP1417961A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide
JP2009513529A (ja) * 2003-07-11 2009-04-02 グラクソ グループ リミテッド ステアリン酸マグネシウムを含む医薬製剤
TW200519108A (en) 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
AP2007004239A0 (en) 2003-10-14 2007-12-31 Glaxo Group Ltd Muscarinic acetycholine receptor antagonists
BRPI0415281A (pt) 2003-10-17 2006-12-19 Glaxo Group Ltd antagonistas de receptor de acetilcolina muscarìnico
PE20050489A1 (es) 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
WO2005095407A1 (en) 2004-03-17 2005-10-13 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
PE20060259A1 (es) 2004-04-27 2006-03-25 Glaxo Group Ltd Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
JP2007537261A (ja) 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
EP1901749B1 (en) 2005-05-18 2016-08-03 Raptor Pharmaceuticals Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2007022351A2 (en) 2005-08-18 2007-02-22 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
GB0525254D0 (en) 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
US7832397B2 (en) 2005-12-28 2010-11-16 Philip Morris Usa Inc. Aerosol powder delivery device
GB0605723D0 (en) 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
LT2400950T (lt) 2009-02-26 2019-08-26 Glaxo Group Limited Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
GB0918249D0 (en) 2009-10-19 2009-12-02 Respivert Ltd Compounds
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2011131663A1 (en) * 2010-04-21 2011-10-27 Chiesi Farmaceutici S.P.A. "process for providing particles with reduced electrostatic charges"
TR201007250A2 (tr) 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.
UY33337A (es) 2010-10-18 2011-10-31 Respivert Ltd DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
JP6021117B2 (ja) 2011-01-31 2016-11-02 ジェノア ファーマシューティカルズ，インク． エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
NZ628072A (en) 2012-03-13 2015-08-28 Respivert Ltd Crystalline pi3 kinase inhibitors
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP2874928B1 (en) 2012-07-19 2016-06-15 Adamis Pharmaceuticals Corporation Powder feeding apparatus
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
JP6799201B2 (ja) 2013-07-31 2020-12-16 アヴァリン ファーマ インク． エアロゾルチロシンキナーゼ阻害剤の化合物、及びその使用
NZ760541A (en) 2014-01-10 2022-08-26 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
DE102016218604A1 (de) 2016-09-27 2018-03-29 Constantin Adams Partikuläres Stoffgemisch, vorzugsweise zur Verwendung bei der Prophylaxe und/oder Behandlung einer Atemwegsstörung
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
WO2023128916A1 (en) * 2021-12-31 2023-07-06 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi An apparatus with a grid (10) for the preparation of dry powder compositions for inhalation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
DE3012136C2 (de) * 1980-03-28 1984-02-16 Bauer, Kurt Heinz, Prof. Dr., 7800 Freiburg Verfahren zur Herstellung eines Granulats

Also Published As

Publication number Publication date
EP0258356B1 (en) 1993-09-22
ES2031839T3 (es) 1993-01-01
AU597964B2 (en) 1990-06-14
FI874710L (fi) 1987-10-26
FI874710A0 (fi) 1987-10-26
HUT46533A (en) 1988-11-28
ZA871523B (en) 1987-08-24
EP0239798A1 (en) 1987-10-07
FI90015C (fi) 1993-12-27
GR3000879T3 (en) 1991-11-15
WO1987005213A1 (en) 1987-09-11
NO874590D0 (no) 1987-11-03
GR880300017T1 (en) 1988-10-18
EP0239798B1 (en) 1990-09-26
NZ219484A (en) 1989-10-27
FI90015B (fi) 1993-09-15
KR880700666A (ko) 1988-04-11
KR940000099B1 (ko) 1994-01-05
ATE94755T1 (de) 1993-10-15
DE258356T1 (de) 1988-09-01
JPS63502895A (ja) 1988-10-27
EP0258356A1 (en) 1988-03-09
HU202748B (en) 1991-04-29
NO874590L (no) 1987-12-30
DE3787502T2 (de) 1994-01-20
AU7164587A (en) 1987-09-28
DE3787502D1 (de) 1993-10-28
IT8619625A0 (it) 1986-03-04
MY102928A (en) 1993-03-31
CA1297012C (en) 1992-03-10

Similar Documents

Publication Publication Date Title
IT1204826B (it) Composizioni farmaceutiche per inalazione
DE69021114D1 (de) Zusatzstoffe, die eine reduzierte Schrumpfung der photohärtbaren Zusammensetzungen gewähren.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
MX10059A (es) Procedimiento para la preparacion de antagonistas de leucotrienos novedosos y producto obtenido
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
DK304485D0 (da) Faste laegemiddelpraeparater med dihydropyridiner samt fremstilling deraf
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
ES465578A1 (es) Procedimiento para la obtencion de preparados farmaceuticos diureticos, antihipertensivos y cardiales
SE8503447L (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
EP0265338A3 (en) Stable therapeutical compositions based on hydrophobic vegetable oil, and process for preparing them
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
FI873192A7 (fi) 1,3-propaanidiamiinijohdannaisia, menetelmä ja farmaseuttisia koostumuksia jotka sisältävät niitä.
IT8720179A0 (it) 2-sulfinil-acetil-1,3-tiazolidine, loro preparazione e composizioni farmaceutiche.
MX5839A (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida, producto obtenido y composicion farmaceutica que lo incluye.
FI883499A7 (fi) Menetelmä aryyli- tai heteroaryylimetyylisubstituoitujen 2.2'-bi-1H-imidatsolien valmistamiseksi
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
IT8520649A0 (it) Derivati dell'ubichinone, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8620713A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per la loro prepazione e relative compisizioni farmaceutiche.
IT8025564A0 (it) Derivati idrosolubili dell'aminaftone, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT1213175B (it) Derivati imidazotiazolmetilen-acetidrazidi, loro preparazione e composizioni farmaceutiche ad attivita'diuretica.